102 related articles for article (PubMed ID: 918689)
1. Morbidity/mortality and economics of hospital-acquired blood stream infections: a controlled study.
Rose R; Hunting KJ; Townsend TR; Wenzel RP
South Med J; 1977 Nov; 70(11):1267-9. PubMed ID: 918689
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
3. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
4. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study.
Landry SL; Kaiser DL; Wenzel RP
Am J Infect Control; 1989 Dec; 17(6):323-9. PubMed ID: 2596729
[TBL] [Abstract][Full Text] [Related]
5. Bacteremic superinfections of patients with bacteremia: occurrence, bacteriology, mortality, and duration of hospitalization at Boston City Hospital during 12 selected years between 1935 and 1972.
Finland M; Barnes MW
J Infect Dis; 1978 Dec; 138(6):829-36. PubMed ID: 739159
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
7. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay.
Martin MA; Pfaller MA; Wenzel RP
Ann Intern Med; 1989 Jan; 110(1):9-16. PubMed ID: 2908834
[TBL] [Abstract][Full Text] [Related]
8. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
9. Hospital costs and mortality attributed to nosocomial bacteremias.
Spengler RF; Greenough WB
JAMA; 1978 Nov; 240(22):2455-8. PubMed ID: 712937
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of outcome of intravenous catheter-related infections in critically ill patients.
Rello J; Ochagavia A; Sabanes E; Roque M; Mariscal D; Reynaga E; Valles J
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1027-30. PubMed ID: 10988125
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
Kirkland KB; Briggs JP; Trivette SL; Wilkinson WE; Sexton DJ
Infect Control Hosp Epidemiol; 1999 Nov; 20(11):725-30. PubMed ID: 10580621
[TBL] [Abstract][Full Text] [Related]
12. Hospital-acquired pneumonia. Attributable mortality and morbidity.
Leu HS; Kaiser DL; Mori M; Woolson RF; Wenzel RP
Am J Epidemiol; 1989 Jun; 129(6):1258-67. PubMed ID: 2729261
[TBL] [Abstract][Full Text] [Related]
13. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
Shorr AF; Zilberberg MD; Micek ST; Kollef MH
Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
[TBL] [Abstract][Full Text] [Related]
14. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.
Garnacho-Montero J; Ortiz-Leyba C; Herrera-Melero I; Aldabó-Pallás T; Cayuela-Dominguez A; Marquez-Vacaro JA; Carbajal-Guerrero J; Garcia-Garmendia JL
J Antimicrob Chemother; 2008 Feb; 61(2):436-41. PubMed ID: 18056733
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of the pathogens responsible for hospital acquired and community acquired late onset neonatal septicemia].
Zhu ML; Zheng G; Chen JN; Lin ZL; Zhu JH; Lin J
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):124-7. PubMed ID: 19099687
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
17. Duration of hospitalization for bacteremic infections at Boston City Hospital during 12 selected years between 1935 and 1972.
Finland M; Barnes MW
J Infect Dis; 1978 Dec; 138(6):837-48. PubMed ID: 368265
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
[TBL] [Abstract][Full Text] [Related]
19. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients.
Blot S; De Bacquer D; Hoste E; Depuydt P; Vandewoude K; De Waele J; Benoit D; De Schuijmer J; Colardyn F; Vogelaers D
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):352-6. PubMed ID: 15865270
[TBL] [Abstract][Full Text] [Related]
20. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
